Challenges and solutions for global shortages of materials for COVID-19 testing

In this episode, Ajin Abraham (Strategic Marketing Manager, Genomics) and Sanna Abbasi, Ph.D. (Scientific Writer/Content Specialist) interview a group of leaders in the Psychiatric Genomics Consortium for Post-Traumatic Stress Disorders (PGC-PTSD). The purpose of the Psychiatric Genomics Consortium is to unite investigators around the world to conduct meta- and mega-analyses of genome-wide data for psychiatric disorders. We talk about the mission of the PGC-PTSD workgroup, how genomics is contributing to discoveries and advancing the field, the impact of advocacy on policy, and the benefits of using saliva for investigation.  

In this podcast, we interview Dr. Jonas Schluter, Assistant Professor from the Department of Microbiology at the Grossman School of Medicine at NYU Langone Health and a winner of the DNA Genotek and Diversigen 2021 Expand into Multi-omics grant, discuss his research.

We invited Alexander Bisignano, CEO of Phosphorus, to tell us more about his company’s application of genetic testing and to share what is in store for them in the future. 

Can the oral microbiome help law enforcement link suspects to crime scenes or evidence? In this episode of Molecules, Microbes and Multiomics Heloise Breton PhD, a product manager at DNA Genotek with a background in forensic science, and Megan Anderson, a recent graduate from Rock Canyon High School, chatted with us about Megan’s project on the oral microbiome in collaboration with the team of scientists at Diversigen.

We recently had the opportunity to interview Dr. Severien Van Keer, a post-doc researcher at the VAXINFECTIO research group, at the University of Antwerp. Her research primarily focuses on Human Papillomavirus (HPV) detection in first-void urine, and the potential of urine as a sample type for cervical cancer screening. Her research also includes Novosanis' Colli-Pee®, a first-void urine collection device.

One new start-up microbiology company, Brick Built, is focused on the potential of the human oral microbiome. Our two microbiome product managers at DNA Genotek, Dr. Heloise Breton, and Laura Cunningham, had the pleasure of speaking with Brick Built Therapeutics co-founder Dr. Brian Klein about the role and future potentials of the oral microbiome in our health and biotech industry.

Shoreline Biome is a microbiome-focused company that provides simple solutions for microbiome next-generation sequencing. They develop tools and reagents to support end-to-end microbiome analysis. We talk about the amazing work of the team at Shoreline Biome and had the pleasure to interview their Director of R&D, Dawn Gratalo. 

In this interview with Dr. Dan Knights, Senior Scientific Advisor of Diversigen, learn about the future of data generation from microbiome samples. Dr. Knights discusses how he started in microbiome and bioinformatics research, ways to increase the power of microbiome studies, and different signals within the microbiome.

In this podcast, we explore how DNA Genotek and Quadrant Biosciences have been working together to support advancements in various diseases via RNA research and collection. Together, they've created RNA tests for early detection of autism spectrum disorder, Parkinson’s disease, traumatic brain injury, and COVID-19.

We interview a team from Duke University in Durham, North Carolina, who are exploring the impact of probiotics in COVID-19 transmission with a new clinical trial: Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC).